MYODA clinical program: composite score for assessing the efficacy of BIO101 (MAS activator) in ambulatory and non-ambulatory Duchenne boys-MedSci.cn

MYODA clinical program: composite score for assessing the efficacy of BIO101 (MAS activator) in ambulatory and non-ambulatory Duchenne boys

Chabane, M; Dioh, W; Dilda, P; Lafont, R; Veillet, S; Voit, T; Agus, S

NEUROMUSCULAR DISORDERS, 2019; 29 (): S178

科室
- - 订阅+
  - 更多科室
工具
服务